Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

272.94
Delayed Data
As of Apr 21
 +0.48 / +0.18%
Today’s Change
205.42
Today|||52-Week Range
307.33
+4.49%
Year-to-Date

Today’s Trading

Previous close272.46
Today’s open272.72
Day’s range271.62 - 274.90
Volume1,127,569
Average volume (3 months)1,670,990
Market cap$58.9B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.66%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+9.37%
P/E ratio16.1
Price/Sales6.09
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.57-0.86%
ILMNIllumina Inc-1.87-1.06%
BIVVBioverativ Inc-0.44-0.76%
NBIXNeurocrine Bioscienc...-0.41-0.80%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$4.99
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs